Perinatal PTSD Diagnoses Rose 394 Percent From 2008 – 2020
The study found the odds of a perinatal PTSD diagnosis were greater for people aged 15 – 26 years, more comorbidities, and a lower income of poverty.
Read More
FDA Approves Iloperidone (Fanapt) for Acute Treatment of Bipolar I Disorder
The FDA approved iloperidone for acute treatment of bipolar I disorder on April 02, 2024, according to Vanda Pharmaceuticals.
All About Autism: Misconceptions, Stigma, Lack of Females in Research
Autism presents differently in males and females, which could explain why fewer females are diagnosed. Females are also often limited or excluded in autism research.
Psychiatry Month in Review: March 2024
This March 2024 psychiatry month in review highlights positive phase 2b and phase 2a data for drugs targeting treatment-resistant depression, generalized anxiety disorder, and PTSD.
College Students Who Abuse Psychoactive Substances Might Land in a “Vicious Loop”
Abusing psychoactive substances, such as ADHD medication, cannabis, and nicotine, not only creates an addiction but can impact mental distress.
FDA Warns About Impella Left-Sided Blood Pumps, Linked to 49 Deaths
FDA issued a warning for the the Impella left-sided blood pumps as it had received many reports of heart-wall tears, increasing the risk of death, hypertension, and more.
BPL-003 Shows Rapid Antidepressant Effect for Treatment-Resistant Depression
A phase 2a open-label study found BL-003 for treatment-resistant depression was well-tolerated and any acute effects resolved on average in less than 2 hours.
KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms
A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.
Women Experience Sleep Disruptions, Heightened Anger in Days Leading Up to Period
A new study found sleep and emotional well-being are impacted days before women get their period.
Social Isolation Linked to Being Older Than Biological Age, Greater Mortality
In a new study, investigators evaluated if social contact influenced the age gap between biological age, estimated with artificial intelligence (AI), and chronological age.
Febuxostat Use Among Gout Asian Patients Linked to Increased Cardiovascular Risk
A meta-analysis found febuxostat was linked to a greater risk for acute coronary syndrome and atrial fibrillation than allopurinol among Asian patients with and without gout.
Depression May Develop as Early as 5 Years After a Stroke
In a recent UK study, more than half of stroke survivors developed depression within 18 years.
Treating Anxiety, Depression in Heart Disease Patients Reduces Hospitalization
The hospitalization risk was reduced to up to 75% for patients with heart disease treated with both antidepressants and psychotherapy to manage anxiety or depression symptoms.
Axsome Therapeutics Announces New SYMPHONY, CRESCENDO Data in Narcolepsy
The SYMPHONY trial found reboxetine can significantly reduce cataplexy, excessive daytime sleepiness, cognitive impairment, depression, and anxiety for patients with narcolepsy.
Self-Guided CBT for Insomnia is Effective for People with Insomnia, Co-Morbid OSA
With limited CBTi-trained psychologists, investigators assessed the effectiveness of a self-guided digital CBTi as another option, so people don’t have to turn to pills.
At-Risk RA Individuals Have Different Views on Preventive Measures
Participants with an RA risk had various opinions on preventive measures, from being on board, needing to be swayed by a doctor, and fearing the intervention.
Rheumatoid Arthritis Patients with Sjögren’s Disease Respond Less to Treatment
A new study found RA patients with concomitant Sjögren’s disease were more likely to fail TNFi treatment than the treatments of other mode of action biologics and JAKi.
BNC210 Brings Significant Improvement in PTSD Symptom Severity
Bionomics announced the release of the full dataset analysis of the ATTUNE phase 2b trial; the data suggests BNC210 for PTSD could have an advantage over approved medications.
Gender Differences in the Treatment Effect of Methotrexate Among RA Patients
A new study evaluated gender differences in physical functioning, sexual dysfunction, depression, fatigue, pain, and loneliness among RA patients using and not using methotrexate.
Chronic Musculoskeletal Pain Linked to Earlier Retirement
Of 1156 participants with chronic musculoskeletal pain, 1073 participants retired at an earlier age. Participants with chronic pain were 1.25 times more likely to stop working.
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
Vice Chair of the Performance Measurement Committee Rebecca A. Andrews spoke to HCPLive about the challenges with performance measures for treating major depressive disorder.
Rebecca Andrews, MD: MDD Performance Measures Review Highlight Need for Tweaking
In an interview with HCPLive, Rebecca Andrews, MD, provided insight into the way the American College of Physicians voted on the performance measures for MDD.
Growth Hormone Somatropin is Effective, Does Not Increase Cancer or Diabetes Risk
The biosimilar recombinant human growth hormone, somatropin, was found to be well-tolerated; only 1.6% of pediatric patients had adverse events suspected to be caused by the injection.
Study Identifies 4 Sleep Patterns to See Impact on Long-Term Health
More than half of the participants were identified as insomnia sleepers and nappers, two suboptimal sleep patterns linked with an increased risk of a chronic condition.
US Middle-Aged Adults Report Loneliness More Than European Adults: Why Is This?
A new study found late baby boomers and Generation X reported greater levels of loneliness than early baby boomers and the Silent Generation.
Aquatic Therapy is Better Than Land-Based Therapy for Women with Fibromyalgia
Aquatic therapy for women with fibromyalgia in Spain is better than land-based therapy for reducing pain levels and improving sleep quality, as seen at the 6-week follow-up.
Bariatric Surgery Cured OSA In a Little More Than Half of Patients After 5 Years
After 5 years, laparoscopic Roux-en-Y gastric bypass cured OSA in 55.1% of patients, and only 20% of patients still had moderate or severe OSA.
Gout Disease Burden Rose from 1990 to 2019 But Will Stay Similar to 2019 Rate by 2030
From 1990 to 2019, the prevalence, incidence, and disability-adjusted life years of gout worldwide increased by 22.4%, 18%, and 22.2%, respectively.
Apremilast for Psoriatic Arthritis Significantly Improves Pain
A new study found the achievement of remission or low disease activity for PsA patients on apremilast was 53.8% by month 12.
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Lindsey Venesky, PhD, discussed how a mental fitness vocal biomarker tool could identify mental health symptoms people might not even be aware of through their voice.